SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-316386
Filing Date
2020-12-14
Accepted
2020-12-14 07:01:00
Documents
14
Period of Report
2020-12-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d826086d8k.htm   iXBRL 8-K 27077
2 EX-99.1 d826086dex991.htm EX-99.1 9647
6 GRAPHIC g8260861.jpg GRAPHIC 9054
  Complete submission text file 0001193125-20-316386.txt   176241

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sppi-20201210.xsd EX-101.SCH 3064
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sppi-20201210_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sppi-20201210_pre.xml EX-101.PRE 11404
7 EXTRACTED XBRL INSTANCE DOCUMENT d826086d8k_htm.xml XML 3404
Mailing Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052
Business Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052 702-835-6300
SPECTRUM PHARMACEUTICALS INC (Filer) CIK: 0000831547 (see all company filings)

IRS No.: 930979187 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35006 | Film No.: 201385069
SIC: 2834 Pharmaceutical Preparations